IRIS
AFELTRA, Antonella Maria Vittoria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 5.014
NA - Nord America 667
EU - Europa 461
OC - Oceania 8
SA - Sud America 8
AF - Africa 4
Totale 6.162
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 4.547
US - Stati Uniti d'America 643
CN - Cina 239
HK - Hong Kong 177
IT - Italia 132
GB - Regno Unito 129
DE - Germania 64
FI - Finlandia 44
NL - Olanda 38
TR - Turchia 20
CA - Canada 18
IN - India 16
CZ - Repubblica Ceca 10
FR - Francia 10
AU - Australia 8
AT - Austria 6
BR - Brasile 6
JP - Giappone 6
UA - Ucraina 6
ES - Italia 5
LT - Lituania 5
MX - Messico 5
HU - Ungheria 2
ID - Indonesia 2
PL - Polonia 2
RU - Federazione Russa 2
SE - Svezia 2
VN - Vietnam 2
ZA - Sudafrica 2
AE - Emirati Arabi Uniti 1
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
CH - Svizzera 1
CL - Cile 1
EE - Estonia 1
ET - Etiopia 1
JO - Giordania 1
KH - Cambogia 1
PA - Panama 1
PE - Perù 1
RS - Serbia 1
SA - Arabia Saudita 1
TN - Tunisia 1
Totale 6.162
Salva come PNG Salva come JPEG
Città #
Singapore 203
Hong Kong 174
Ashburn 158
London 120
Boardman 115
Hefei 105
Shanghai 71
Council Bluffs 53
Munich 47
West Jordan 40
Rome 35
Amsterdam 30
Los Angeles 29
Helsinki 22
San Francisco 22
Turku 22
Sona 20
Seattle 19
Washington 19
Bari 15
Ankara 13
Santa Clara 13
Pune 11
Toronto 11
Brno 10
Changsha 7
Tokyo 6
Boston 5
Brooklyn 5
Charlotte 5
Milan 5
São Paulo 5
Chengdu 4
Duino-Aurisina 4
Haikou 4
Naples 4
New York 4
Noicattaro 4
State College 4
Beijing 3
Paris 3
Redmond 3
Sydney 3
The Dalles 3
Vienna 3
Brest 2
Canberra 2
Central 2
Chennai 2
Chicago 2
Cuernavaca 2
Guiyang 2
Handan 2
Herne Bay 2
Ho Chi Minh City 2
Linyi 2
Melbourne 2
Messina 2
Mexico City 2
Montreal 2
Perugia 2
Reus 2
Rockville 2
Secaucus 2
Tianjin 2
Vilnius 2
Warsaw 2
Ajman 1
Almere Stad 1
Amman 1
Annapolis 1
Augusta 1
Belgrade 1
Bologna 1
Borås 1
Bourne 1
Budapest 1
Calgary 1
Charleston 1
Clifton 1
Cold Lake 1
Columbia 1
Dallas 1
Delhi 1
Denver 1
Dongguan 1
Foggia 1
Foligno 1
Guangzhou 1
Houston 1
Jiangmen 1
Jianning 1
Jiaxing 1
Johannesburg 1
Krasnoyarsk 1
Lima 1
Lincoln 1
Luoyang 1
Lüleburgaz 1
Manchester 1
Totale 1.538
Salva come PNG Salva come JPEG
Nome #
Angiogenic cytokines in patients undergoing antiviral treatment for chronic hepatitis C virus infection 193
A case of Henoch-Schönlein purpura in the elderly: not just a 'second childhood' 193
A mocking finding: portal cavernoma mimicking neoplastic mass. First sign of myeloproliferative disorder in a patient with Janus kinase2 V617F mutation 190
Cardiovascular safety of anti-TNF-alpha therapies: Facts and unsettled issues. 189
Apoptosis and autoimmunity induced by clodronate in systemic lupus erythematosus mononuclear circulating cells 189
Anti-tumor necrosis factor-alpha reverts growth hormone resistance associated with inflammatory bowel disease 187
Deep vein thrombosis, inferior vena cava interruption and multiple thrombophilic gene mutations 185
Iloprost: an adjunctive approach to chronic viral hepatitis treatment 183
Retroperitoneal fibrosis and ankylosing spondylitis: which links? 178
New onset of psoriasis induced by secukinumab in a patient with ankylosing spondylitis: a case report 177
Relationship between leptin and regulatory T cells in systemic lupus erythematosus: preliminary results 169
Polypharmacy in older people: Lessons from 10 years of experience with the REPOSI register 167
Leptin in immuno-rheumatological diseases 164
Implementation of the Frailty Index in hospitalized older patients: Results from the REPOSI register 163
Improved hepatic perfusion after iloprost infusion in patients with HCV chronic infection: a pilot study with possible therapeutic implications 101
GH-resistance in different stages of chronic liver disease 96
Diabetes in chronic liver disease: from old concepts to new evidence 92
Enhanced portal flow velocity and volume following Iloprost treatment 91
Automatic acquisition of Immunofluorescence images: algorithms and evaluation 91
Pancreatitis after percutaneous ethanol injection into HCC: a minireview of the literature 90
Growth hormone-stimulated insulin-like factor-1 and acid labile subunit in chronic liver disease 89
Percutaneous ultrasound-guided ablation of BW7756-hepatoma using ethanol or acetic acid in a rat model 85
Radiofrequency ablation of hepatic tissue: a new experimental animal model 85
Iloprost enhances portal flow velocity and volume in patients with systemic sclerosis 83
Duration of clinical remission and low disease activity impacts on quality of life and its domains in psoriatic arthritis patients: results from an Italian multicentre study 83
Anti-tumor necrosis factor α: originators versus biosimilars, comparison in clinical response assessment in a multicenter cohort of patients with inflammatory arthropathies 82
Clinical features of patients with systemic lupus erythematosus according to health-related quality of life, entity of pain, fatigue and depression: a cluster analysis 81
Cannabinoids in Autoimmune and Rheumatic Diseases 78
Angiogenic and angiostatic factors in renal scleroderma-associated vasculopathy 77
Endocannabinoid system in systemic lupus erythematosus: First evidence for a deranged 2-arachidonoylglycerol metabolism 77
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management. 77
Prognostic value of degree and types of anaemia on clinical outcomes for hospitalised older patients 76
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients 76
Portal diameter in the diagnosis of esophageal varices in 266 cirrhotic patients: which role? 75
Cardiovascular Risk Prediction in Ankylosing Spondylitis: From Traditional Scores to Machine Learning Assessment 75
Leptin in autoimmune mechanisms of systemic rheumatic diseases 74
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both 73
ANA testing in ‘real life’ 73
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 69
Endothelial dysfunction and activation as an expression of disease: role of prostacyclin analogs 69
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 65
Hyperglycemia at admission, comorbidities, and in-hospital mortality in elderly patients hospitalized in internal medicine wards: data from the RePoSI Registry 62
SARS-CoV-2 infection in patients with primary Sjögren syndrome: characterization and outcomes of 51 patients 59
A machine-learning approach to cardiovascular risk prediction in psoriatic arthritis 58
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 57
Demographic and clinical differences between ankylosing spondylitis and non-radiographic axial spondyloarthritis: results from a multicentre retrospective study in the Lazio region of Italy 55
Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry 54
Defining aging phenotypes and related outcomes: Clues to recognize frailty in hospitalized older patients 45
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 42
Role of the specialized proresolving mediator resolvin D1 in systemic lupus erythematosus: preliminary results 40
Mediterranean diet and Psoriatic Arthritis activity: a multicenter cross-sectional study 34
Occurrence and predictive factors of high blood pressure, type 2 diabetes, and metabolic syndrome in rheumatoid arthritis: findings from a 3-year, multicentre, prospective, observational study 33
TNF-alpha and growth hormone resistance in patients with chronic liver disease 30
The association between duration of remission, fatigue, depression and health-related quality of life in Italian patients with systemic lupus erythematosus 26
The Role of Ribavirin in the Combination Therapy of Hepatitis C Virus Infection 26
JAK inhibitors in immune-mediated rheumatic diseases: From a molecular perspective to clinical studies 25
One-year effectiveness, retention rate, and safety of secukinumab in ankylosing spondylitis and psoriatic arthritis: a real-life multicenter study 24
Late-Onset and Elderly Psoriatic Arthritis: Clinical Aspects and Management 24
The relation between, metabolic syndrome and quality of life in patients with Systemic Lupus Erythematosus 24
Low level tumor necrosis factor-alpha protects cardiomyocytes against high level tumor necrosis factor-alpha: brief insight into a beneficial paradox 24
Female sexual dysfunction in systemic sclerosis: The role of endothelial growth factor and endostatin 23
Primary prevention of cardiovascular disease in patients with systemic lupus erythematosus: case series and literature review 23
Subcellular shift of the hepatic growth hormone receptor with progression of hepatitis C virus-related chronic liver disease 22
Infliximab reverses growth hormone resistance associated with inflammatory bowel disease 22
The classification of Crithidia luciliae immunofluorescence test (CLIFT) using a novel automated system 21
Matters of the heart: The case of TNF-alpha targeting drugs 21
Prognostic relevance of glomerular filtration rate estimation obtained through different equations in hospitalized elderly patients 21
Retention rates and identification of factors associated with anti-TNFα, anti-IL17, and anti-IL12/23R agents discontinuation in psoriatic arthritis patients: results from a real-world clinical setting 21
Pain and Frailty in Hospitalized Older Adults 21
Ultrasound detection of subclinical synovitis in rheumatoid arthritis patients in clinical remission: a new reduced-joint assessment in 3 target joints 20
Prolonged remission is associated with a reduced risk of cardiovascular disease in patients with systemic lupus erythematosus: a GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study 20
Early Spondyloarthritis Clinic: Organizational Improvements in the Patient Journey 20
The growing role of precision medicine for the treatment of autoimmune diseases; results of a systematic review of literature and Experts' Consensus 20
The IL33/ST2 axis in Sjogren syndrome in relation to disease activity 19
Physical activity and sedentary behavior in patients with Systemic Lupus Erythematosus 19
Surgical complications after resection of adrenal carcinoma 19
Moderate-to-severe plaque psoriasis, described by PASI ≥10%, can be associated with higher cardiovascular risk according to seven risk algorithms: Results of a 10-year single-center retrospective study and clinical management of psoriatic patients with cardiovascular risk 19
Pattern of sleep dysfunction in systemic lupus erythematosus: a cluster analysis 19
Erectile dysfunction: Imbalance between pro-angiogenic and anti-angiogenic factors in systemic sclerosis 18
Utility of ultrasound in the diagnosis of chronic worsened gout 18
Polyunsaturated fatty acids: any role in rheumatoid arthritis? 18
The multifaceted spectrum of liver cirrhosis in older hospitalised patients: Analysis of the REPOSI registry 18
Indirect immunofluorescence in autoimmune diseases: assessment of digital images for diagnostic purpose 18
Performances of five risk algorithms in predicting cardiovascular events in patients with Psoriatic Arthritis: An Italian bicentric study 18
Metabolic syndrome and adipokine levels in systemic lupus erythematosus and systemic sclerosis 18
Homocysteinylated alpha 1 antitrypsin as an antigenic target of autoantibodies in seronegative rheumatoid arthritis patients 18
Intrarenal arterial stiffness is increased in systemic sclerosis patients with anti-ribonucleic acid polymerase III antibodies 17
Serum level of endostatin and digital ulcers in systemic sclerosis patients 17
Evaluation of the influence of social, demographic, environmental, work-related factors and/or lifestyle habits on Raynaud's phenomenon: a case-control study 16
Persistence of C-reactive protein increased levels and high disease activity are predictors of cardiovascular disease in patients with axial spondyloarthritis 16
Performance and calibration of the algorithm ASSIGN in predicting cardiovascular disease in Italian patients with psoriatic arthritis 16
Strain Ultrasound Elastography in the Achilles Tendon of Ankylosing Spondylitis Patients Treated With Anti-TNF-α: A Preliminary Study. 16
Pro-inflammatory adipokine profile in psoriatic arthritis: results from a cross-sectional study comparing PsA subset with evident cutaneous involvement and subset "sine psoriasis". 16
Peripheral graft infection due to Staphylococcus aureus without abnormal findings by 99mTc-HMPAO-labeled-leukocyte scan 16
Parasympathetic activity increases with digital microvascular damage and vascular endothelial growth factor in systemic sclerosis 15
Non-cirrhotic portal hypertension with large regenerative nodules: a diagnostic challenge 15
In systemic sclerosis, microvascular and hands digital arteries damage correlates with serum levels of endostatin 14
Tumour necrosis factor alpha (TNFα)cardiomyocyte preconditioning: clues to explain anti-TNFα agents contraindication in severe heart failure 14
The inter-observer reading variability in anti-nuclear antibodies indirect (ANA) immunofluorescence test: A multicenter evaluation and a review of the literature 14
Tnf-alpha induced cardioprotection: effects on reactive oxygen species (ros) and apoptosis 14
Totale 6.182
Salva come PNG Salva come JPEG
Categoria #
all - tutte 36.894
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.894
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022133 0 1 0 0 1 2 2 6 14 4 2 101
2022/2023137 19 0 0 2 38 2 8 7 2 3 55 1
2023/2024439 26 39 20 37 34 167 5 25 5 48 12 21
2024/20255.517 58 41 143 42 94 123 40 25 265 355 1.874 2.457
2025/20262 2 0 0 0 0 0 0 0 0 0 0 0
Totale 6.228